Hochschulschrift
Chimeric antigen receptor-redirected regulatory T cells as a therapy for multiple sclerosis and other neurological diseases
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
IX, 183 Blätter
- Sprache
-
Englisch
- Anmerkungen
-
Illustrationen, Diagramme
Medizinische Hochschule Hannover, Dissertation, 2023
- Ereignis
-
Veröffentlichung
- (wo)
-
Hannover
- (wann)
-
2023
- Urheber
- Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:50 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Entstanden
- 2023
Ähnliche Objekte (12)
Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation
Chimeric Antigen Receptor T-Cell Therapy
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Optimization of chimeric antigen receptor (CAR) therapy
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease
Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation
Chimeric Antigen Receptor T-Cell Therapy
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Optimization of chimeric antigen receptor (CAR) therapy
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor
Feasibility of manufacture of chimeric antigen receptor-regulatory T cells from patients with end-stage renal disease
Preclinical assessment of antigen-specific chimeric antigen receptor regulatory T cells for use in solid organ transplantation
Chimeric Antigen Receptor T-Cell Therapy
Regulatory T cells expressing CD19-targeted chimeric antigen receptor restore homeostasis in Systemic Lupus Erythematosus
Antigen-induced chimeric antigen receptor multimerization amplifies on-tumor cytotoxicity
Chimeric antigen receptor–based therapies beyond cancer
Optimization of chimeric antigen receptor (CAR) therapy
Allogeneic Chimeric Antigen Receptor Therapy in Lymphoma
Engineering better chimeric antigen receptor T cells
Multi-antigen-targeted chimeric antigen receptor T cells for cancer therapy
Targeting cardiac fibrosis with chimeric antigen receptor macrophages
Effectors of the Future: Universal Chimeric Antigen Receptor